Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Brain
Alpha Bites Under Review: The Truth About Alpha Bites and Its Daily Boost for “Alpha” Performance
LAKELAND, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Alpha Bites has burst onto the men’s wellness scene as a game-changing...
Orchard Therapeutics Announces Reimbursement Agreement in Spain
LONDON, MADRID, and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it has recently...
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as...
LA FIRE VICTIMS CAN RELEASE SOME OF THE STRESS: NUCALM AND TONY ROBBINS JOIN FORCES TO GIVE BACK
NuCalm Donates One-Year Membership to their Mobile App to Help Families Heal from the Trauma of Loss and Displacement WILMINGTON,...
Carson Leslie Foundation Expands Collaboration with the Children’s Brain Tumor Network
PHILADELPHIA, Feb. 27, 2025 /PRNewswire/ -- The Children's Brain Tumor Network (CBTN) announces the addition of the Carson Leslie Foundation...
Pusan National University Develops One-Step 3D Microelectrode Technology for Neural Interfaces
A new one-step fabrication method improves the design of flexible 3D microelectrode arrays for neural applications BUSAN, South Korea, Feb....
EudaLife™ Magazine Launches Nationwide – Pre-Orders Begin March 20th, 2025 via Amazon Prime
AUSTIN, Texas, Feb. 27, 2025 /PRNewswire/ -- EudaLife™ Magazine, the definitive guide for affluent professionals seeking to optimize health and...
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
New study leverages Precision’s Layer 7 Cortical Interface for high-resolution brain mapping during craniotomy proceduresNEW YORK, Feb. 27, 2025 (GLOBE...
Orbus Therapeutics Appoints Jason Levin, Co-founder and COO to President
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the...
Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe
OXFORD, England, Feb. 27, 2025 /PRNewswire/ -- Brainomix, a pioneer in stroke AI imaging software and European market leader, has...
FINN Partners and Humble Ventures Expanded ‘Future of Education and Health’ Returns to Austin on Thursday, March 6 – Friday, March 7 at Atelier 1205
Two immersive future-focused days of programming in education and health, bringing together leading innovators, VCs, policymakers, researchers and entrepreneurs for...
Philips accelerates precise imaging with unique AI technologies in MRI to improve patient outcomes
Dual AI engines in SmartSpeed Precise SmartSpeed Precise pelvis clinical image SmartSpeed Precise knee clinical image SmartSpeed Precise sinus clinical...
Eterna Therapeutics Hosts Successful Inaugural Meeting with Newly Formed Scientific Advisory Board to Advance Cell Therapy Pipeline
Meeting addressed progress and strategic direction for company’s induced mesenchymal stem cell (iMSC) therapy programsCAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE...
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary...
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure...
Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides...
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
February 24, 2025 Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use Biodexa plans to...